Scienture Holdings, Inc. (SCNX) intrinsic value & 10-year financials
Scienture Holdings, Inc. (SCNX) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue shrank 17.7% a year to $431.6K, with an average return on invested capital of -87.5%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $3.36
- Market cap
- $51.6M
- Revenue (FY2025)
- $431.6K
- Revenue growth (10-yr CAGR)
- -17.7%
- ROIC (10-yr avg)
- -87.5%
- Free cash flow (FY2025)
- —
SCNX 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $431.6K | -$41.5M | -$2.70 | — | -9867.9% | — |
| FY2024 | $136.6K | $9.1M | $2.48 | -$14.3M | -10758.7% | -33.1% |
| FY2023 | $8.3M | -$17.8M | -$7.49 | — | -87.8% | -438.5% |
| FY2022 | $11.4M | -$3.5M | -$0.41 | — | -38.6% | -254.0% |
| FY2021 | $9.9M | -$5.3M | -$0.65 | -$2.6M | -53.5% | -213.8% |
| FY2020 | $17.1M | -$2.5M | — | -$2.3M | -14.6% | -93.3% |
| FY2019 | $7.4M | -$284.4K | -$0.05 | — | 1.7% | -21.3% |
| FY2018 | $3.8M | $9.0K | $0.00 | — | -2.3% | 2.7% |
| FY2017 | $2.9M | $289.0K | $0.01 | — | 13.5% | -99.9% |
| FY2016 | $2.5M | -$2.8M | -$0.09 | — | -39.6% | 363.3% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Scienture Holdings, Inc. is facing top-line stagnation, with revenue contracting over the decade.
Scienture Holdings, Inc. has historically struggled to out-earn its cost of capital, averaging just -27.8% ROIC.
Over the decade, Scienture Holdings, Inc. shows that management has aggressively returned capital to shareholders by retiring 51.3% of outstanding shares.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Scienture Holdings, Inc. is modeled at -17.7% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-57.38 per share.